LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
26.72
-1.18 (-4.23%)
At close: Dec 5, 2025, 4:00 PM EST
26.71
-0.01 (-0.04%)
After-hours: Dec 5, 2025, 7:56 PM EST
LENZ Therapeutics Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for LENZ Therapeutics stock ranges from a low of $50 to a high of $67. The average analyst price target of $56.25 forecasts a 110.52% increase in the stock price over the next year.
Price Target: $56.25 (+110.52%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 20, 2025.
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Reiterates $40 → $50 | Buy | Reiterates | $40 → $50 | +87.13% | Oct 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $51 → $67 | Buy | Maintains | $51 → $67 | +150.75% | Oct 10, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $49 → $52 | Strong Buy | Maintains | $49 → $52 | +94.61% | Aug 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $56 | Strong Buy | Maintains | $48 → $56 | +109.58% | Aug 1, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $49 | Strong Buy | Maintains | $45 → $49 | +83.38% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
17.40M
Revenue Next Year
53.02M
from 17.40M
Increased by 204.72%
EPS This Year
-2.69
from -2.34
EPS Next Year
-2.86
from -2.69
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 22.7M | 63.6M | ||||
| Avg | 17.4M | 53.0M | ||||
| Low | 5.9M | 40.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 265.7% | ||||
| Avg | - | 204.7% | ||||
| Low | - | 131.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.57 | -2.09 | ||||
| Avg | -2.69 | -2.86 | ||||
| Low | -2.68 | -3.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.